Abstract
Free full text
Point Mutation of the E–Cadherin Gene in Invasive Lobular Carcinoma of the Breast
Abstract
Reduced or heterogeneous expression of E–cadherin has been demonstrated immunohistochemically in poorly differentiated carcinoma, which frequently shows weak intercellular adhesiveness and marked invasiveness. In vitro, not only reduced expression but also structural abnormalities of E–cadherin have been observed in human carcinoma cell lines which grow in a loosely adhering manner. To clarify the participation of structural abnormalities of E–cadherin in cancer invasion in vivo, sequence abnormalities were examined in the cadherin domain (exons 5, 6, 7 and 8) including the region essential for E–cadherin specific binding, using the polymerase chain reaction–single–strand conformation polymorphism method and direct sequencing in invasive lobular carcinoma of the breast, in which cancer cells become detached from each other and invade the stroma in a particularly scattered pattern. In 2 (10%) of the 20 cases examined, an identical sequence abnormality was detected in E–cadherin exon 7, i.e. a point mutation of codon 315 (AAT to AGT) which resulted in a single ainino acid substitution (asparagine to serine). This mutation may abolish the E–cadherin–mediated cell–cell adhesion and be at least partly responsible for the weak intercellular adhesiveness and scattered histological pattern of the tumor.
REFERENCES
Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley
Full text links
Read article at publisher's site: https://doi.org/10.1111/j.1349-7006.1994.tb02902.x
Read article for free, from open access legal sources, via Unpaywall: https://europepmc.org/articles/pmc5919349?pdf=render
Citations & impact
Impact metrics
Citations of article over time
Article citations
Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells via Erk1/Erk2 and β-Catenin Signaling Pathways.
Front Oncol, 11:630408, 12 Mar 2021
Cited by: 6 articles | PMID: 33777781 | PMCID: PMC7994530
E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations.
Hum Pathol, 102:44-53, 26 Jun 2020
Cited by: 13 articles | PMID: 32599083 | PMCID: PMC7484442
High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
BMC Cancer, 20(1):602, 29 Jun 2020
Cited by: 6 articles | PMID: 32600359 | PMCID: PMC7325041
The Interaction of CDH20 With β-Catenin Inhibits Cervical Cancer Cell Migration and Invasion via TGF-β/Smad/SNAIL Mediated EMT.
Front Oncol, 9:1481, 09 Jan 2020
Cited by: 11 articles | PMID: 31998642 | PMCID: PMC6962355
RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
Cell Death Dis, 9(11):1085, 22 Oct 2018
Cited by: 10 articles | PMID: 30348939 | PMCID: PMC6197279
Go to all (80) article citations
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
EMBO J, 14(24):6107-6115, 01 Dec 1995
Cited by: 442 articles | PMID: 8557030 | PMCID: PMC394735
Diffuse growth pattern affects E-cadherin expression in invasive breast cancer.
Anticancer Res, 24(4):2237-2242, 01 Jul 2004
Cited by: 10 articles | PMID: 15330167
Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas.
Mol Pathol, 54(2):91-97, 01 Apr 2001
Cited by: 24 articles | PMID: 11322170 | PMCID: PMC1187009
CDH1 germline mutations and hereditary lobular breast cancer.
Fam Cancer, 15(2):215-219, 01 Apr 2016
Cited by: 54 articles | PMID: 26759166
Review